Jeff Auxier's ELV Position Overview
Jeff Auxier (via Auxier Asset Management LLC) currently holds 36,541 shares of Elevance Health, Inc. (ELV) worth $12.81 M, representing 1.80% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 45 quarters.
Based on 13F filings since 2013, Jeff Auxier has maintained a long-term strategic position in ELV, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2019, adding 1,000 shares. Largest reduction occurred in Q2 2024, reducing 6,529 shares.
Analysis based on 13F filings available since 2013 Q2
Jeff Auxier's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by Jeff Auxier
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -555 | Reduce 1.50% | 36,541 | $350.55 |
| Q3 2025 | +343 | Add 0.93% | 37,096 | $323.12 |
| Q2 2025 | +681 | Add 1.89% | 36,753 | $388.96 |
| Q1 2025 | +430 | Add 1.21% | 36,072 | $434.96 |
| Q4 2024 | -1,573 | Reduce 4.23% | 35,642 | $368.90 |
| Q3 2024 | +10 | Add 0.03% | 37,215 | $520.00 |
| Q2 2024 | -6,529 | Reduce 14.93% | 37,205 | $541.86 |
| Q1 2024 | -2,350 | Reduce 5.10% | 43,734 | $518.54 |
| Q4 2023 | -244 | Reduce 0.53% | 46,084 | $471.56 |
| Q3 2023 | -35 | Reduce 0.08% | 46,328 | $435.42 |
| Q2 2023 | -45 | Reduce 0.10% | 46,363 | $444.29 |
| Q1 2023 | -128 | Reduce 0.28% | 46,408 | $459.81 |
| Q4 2022 | -33 | Reduce 0.07% | 46,536 | $512.97 |
| Q3 2022 | -14 | Reduce 0.03% | 46,569 | $454.25 |
| Q2 2022 | -31 | Reduce 0.07% | 46,583 | $482.58 |
| Q1 2022 | -1,060 | Reduce 2.22% | 46,614 | $491.23 |
| Q4 2021 | -162 | Reduce 0.34% | 47,674 | $463.54 |
| Q3 2021 | -38 | Reduce 0.08% | 47,836 | $372.79 |
| Q2 2021 | -595 | Reduce 1.23% | 47,874 | $381.79 |
| Q1 2021 | -100 | Reduce 0.21% | 48,469 | $358.95 |
| Q4 2020 | -60 | Reduce 0.12% | 48,569 | $321.09 |
| Q3 2020 | +80 | Add 0.16% | 48,629 | $268.58 |
| Q2 2020 | +495 | Add 1.03% | 48,549 | $262.97 |
| Q1 2020 | -555 | Reduce 1.14% | 48,054 | $227.04 |
| Q4 2019 | +360 | Add 0.75% | 48,609 | $302.02 |
| Q3 2019 | -50 | Reduce 0.10% | 48,249 | $240.11 |
| Q2 2019 | +1,000 | Add 2.11% | 48,299 | $282.20 |
| Q1 2019 | -2,160 | Reduce 4.37% | 47,299 | $286.98 |
| Q3 2018 | -287 | Reduce 0.58% | 49,459 | $274.05 |
| Q2 2018 | -413 | Reduce 0.82% | 49,746 | $238.03 |
| Q1 2018 | +465 | Add 0.94% | 50,159 | $219.70 |
| Q4 2017 | -625 | Reduce 1.24% | 49,694 | $225.02 |
| Q3 2017 | -1,800 | Reduce 3.45% | 50,319 | $189.89 |
| Q2 2017 | -75 | Reduce 0.14% | 52,119 | $188.13 |
| Q1 2017 | -2,500 | Reduce 4.57% | 52,194 | $165.38 |
| Q4 2016 | -150 | Reduce 0.27% | 54,694 | $143.76 |
| Q3 2016 | -1,200 | Reduce 2.14% | 54,844 | $125.32 |
| Q1 2016 | -200 | Reduce 0.36% | 56,044 | $139.00 |
| Q3 2015 | -50 | Reduce 0.09% | 56,244 | $140.00 |
| Q2 2015 | -5,700 | Reduce 9.19% | 56,294 | $164.14 |
| Q1 2015 | -1,142 | Reduce 1.81% | 61,994 | $154.40 |
| Q4 2014 | +63,136 | New Buy | 63,136 | $125.67 |
Jeff Auxier's Elevance Health Investment FAQs
Jeff Auxier first purchased Elevance Health, Inc. (ELV) in Q4 2014, acquiring 63,136 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeff Auxier has held Elevance Health, Inc. (ELV) for 45 quarters since Q4 2014.
Jeff Auxier's largest addition to Elevance Health, Inc. (ELV) was in Q4 2014, adding 63,136 shares worth $7.93 M.
According to the latest 13F filing for Q4 2025, Jeff Auxier's firm, Auxier Asset Management LLC, owns 36,541 shares of Elevance Health, Inc. (ELV), valued at approximately $12.81 M.
As of the Q4 2025 filing, Elevance Health, Inc. (ELV) represents approximately 1.80% of Jeff Auxier's publicly disclosed stock portfolio, making it one of their key holdings.
Jeff Auxier's peak holding in Elevance Health, Inc. (ELV) was 63,136 shares, as reported at the end of Q4 2014.